Haiying Grunenwald

Illumina: At Illumina, their goal is to apply innovative technologies to genetic variation and function analysis, making studies possible that were not even imaginable just a few years ago. It is mission-critical for them to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places a high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, they strive to meet this challenge. Illumina’s innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

Bio Highlights: Haiying is a Director of Product Development at Illumina Inc.  She has a strong track record of driving successful product development and has led some of the company’s most impactful product launches in research, clinical, and applied markets. Haiying received her Ph.D. in Molecular, Cellular, Developmental Biology and Genetics from the University of Minnesota – Twin Cities. She conducted in-depth studies on the effects of connexins and gap junctions on cellular communication and cancer. She has garnered a reputation for leading teams as catalysts of change that advanced Illumina’s NGS portfolio, drove research discoveries, and improved patient care globally. Born and raised in China and an avid world traveler, Haiying strives to bridge the Asian and western cultures and ideologies. In doing so, she thrives on facilitating success through collaboration, tolerance, and inclusion.